Author:
Vengeliene Valentina,Takahashi Tatiane T.,Dravolina Olga A.,Belozertseva Irina,Zvartau Edwin,Bespalov Anton Y.,Spanagel Rainer
Funder
Bundesministerium für Bildung und Forschung
CAPES Foundation, Ministry of Education of Brazil
Publisher
Springer Science and Business Media LLC
Reference45 articles.
1. Agabio R, Colombo G (2014) GABAB receptor ligands for the treatment of alcohol use disorder: preclinical and clinical evidence. Front Neurosci 8:140
2. ANSM (2017) Le Baclofène en vie réelle en France entre 2009 et 2015. Usages, persistance et sécurité, et comparaison aux traitements des problèmes d’alcool ayant une autorisation de mise sur le marché. Rapport – 25th of July, 2017 - www.ansm.sante.fr
3. Beraha EM, Salemink E, Goudriaan AE, Bakker A, de Jong D, Smits N, Zwart JW, Geest DV, Bodewits P, Schiphof T, Defourny H, van Tricht M, van den Brink W, Wiers RW (2016) Efficacy and safety of high-dose baclofen for the treatment of alcohol dependence: a multicentre, randomised, double-blind controlled trial. Eur Neuropsychopharmacol 26:1950–1959
4. Besheer J, Lepoutre V, Hodge CW (2004) GABA(B) receptor agonists reduce operant ethanol self-administration and enhance ethanol sedation in C57BL/6J mice. Psychopharmacology 174:358–366
5. Beveridge TJ, Smith HR, Porrino LJ (2013) Differential development of tolerance to the functional and behavioral effects of repeated baclofen treatment in rats. Pharmacol Biochem Behav 106:27–32
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献